Novo Nordisk A/S

Novo Nordisk A/S (Novo Nordisk) is a global healthcare company, which is engaged in the development, manufacture, marketing and distribution of diabetes care products. The company also focuses on haemostasis management, growth hormone therapy and hormone replacement therapy. It classifies its operations into two reporting segments, namely, Diabetes Care and Biopharmaceuticals. Novo Nordisk has one of the broadest diabetes product portfolios, including the most advanced products in the area of insulin delivery system. The company has a network of subsidiaries and affiliates in 76 countries throughout the world. Its products are sold in over 179 countries across the globe through subsidiaries and distributors network. Novo Nordisk is headquartered in Bagsvaerd, Denmark.